Shares in Incathera PLC shot up 70% in early trading after the developer of skin care products revealed its deal with Switzerland's Marionnaud is ramping up faster than anticipated.
Its first order has been doubled, while it expects to bank £10m in sales next year and £33m the year after as a result of the tie-up.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) told investors it is nearing the completion of its flow testing operations at the Hickory-1 well, part of its Project Phoenix acreage on the North Slope of Alaska.
The company indicated that the Upper SFS (USFS) flow testing operations are almost finished, with results expected to be announced by the end of this week.
Incanthera PLC (AQSE:INC) said it expects to generate revenues of £10 million next financial year, and, crucially, be profitable as it announced a significant step up in business with Switzerland's Marionnaud.
The step change after this is even more dramatic, with the skincare group predicting its revenues for the 12 months ended March 31, 2026.
Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) said its light-activated antimicrobial technology, Steriwave, will be adopted by an NHS trust, starting with Pontefract and Pinderfields hospitals.
This initiative, aimed at reducing surgical site infections (SSIs) among hip and knee surgery patients, marks Steriwave's first commercial adoption within the UK health service framework.